DocWire News Editors

DocwireNews

As the coronavirus disease 2019 (COVID-19) spread around the world, reports of renal involvement varied across regions. Kam wa Chan, MD, and colleagues at the University of Hong Kong and the London School of Hygiene and Tropical Medicine conducted a review and meta-analysis to assess the global prevalence of renal manifestations among patients with COVID-19 and identify the risk factors associated with acute kidney injury (AKI) related to COVID-19.The researchers reported results of the analysis during a virtual poster session at ASN Kidney Week 2020. The poster was titled Renal Involvement in Coronavirus Disease 2019 (RECORD): A Systematic Review and Meta-Analysis.The researchers systematically searched six databases for peer-reviewed reports and seven data portals for grey literature for all trials, cohorts, case-control studies, and case-series reporting the prevalence of renal manifestations of COVID-19, including AKI, renal replacement therapy (RRT), proteinuria and hematuria, and their associated risk factors. Papers were screened by a minimum of two independent researchers.Study quality was determined using National Institutes of Health assessment tools. Location, institutions, and time periods were matched to avoid duplication of patient data, and if studies overlapped, the meta-analysis only included the largest data source. The pooled prevalence of renal manifestations was obtained from studies that consecutively recruited patients from the general population and those with a clear definition of outcome. The review was prospectively registered at PROSPERO (CRD42020184621).The search yielded 36 studies from eight countries and more than 50 cities, representing a total of 14,712 patients. Thirty-four of the studies were cohort studies and two were case-control studies. Of the 36 studies, 24 included COVID-19 patients from the general population, seven included severe/critical patients, and five reported results of patients with a history of RRT.Overall, AKI occurred in 14.3% of COVID-19 cases, with the highest prevalence in New York City. Of hospitalized COVID-19 patients, 4.7% underwent RRT. Proteinuria and hematuria were observed in 42.5% and 26.7% of all COVID-19 cases, respectively.The odds of mortality among COVID-19 patients with AKI were 15 times higher than among non-AKI COVID-19 patients (pooled odds ratio [OR], 16.85; 95% confidence interval [CI], 10.06-28.23; results from two cities, six studies, 9297 patients). The odds of mortality were higher in the province of Hubei, China. Increased risk of mortality was not seen in kidney transplant recipients (pooled OR, 0.95; 95% CI, 0.12-7.22; results from two studies, 30 patients).There were associations between higher C-reactive protein, leukocyte count, serum lactate dehydrogenase, and creatinine levels on admission and AKI.&ldquo;AKI was prevalent among COVID-19 patients and significantly associated with mortality. The odds of mortality among AKI patients varied significantly between cities, which could be associated with differences in healthcare infrastructure and delayed hospitalization and treatment initiation,&rdquo; the researchers said.Read more here: <a href="https://www.asn-online.org/education/kidneyweek/2020/program-abstract.aspx?controlId=3447802">https://www.asn-online.org/education/kidneyweek/2020/program-abstract.aspx?controlId=3447802</a>Source: Chan Kw, Yu KY, Lee PW, Tang SC. Renal involvement in coronavirus disease 2019 (RECORD): A systematic review and meta-analysis. Abstract of a poster presented at the American Society of Nephrology virtual Kidney Week 2020 (PO0661), October 22, 2020.

Meghan Sise, MD

Joel M. Topf, MD, FACP

Redefining Carboplatin Dosing

NKF Spring Clinical Meetings 2025

MarkAlain Déry, DO

The Significant Danger Measles Pose for Unvaccinated Children

Infectious Disease

Andrew Moreno

Antithrombotic Care in Hemophilia: A Summary of Multi-Organizational Clinical Practice Guidance

Hemophilia

Latest News

AKI in Patients with Coronavirus Disease 2019: Systematic Review and Meta-Analysis

ASN Kidney Week 2020

As the coronavirus disease 2019 (COVID-19) spread around the world, reports of renal involvement varied across regions. Kam wa Chan, MD, and colleagues at the University of ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe